(Q43276755)

18 November 2017

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease (English)

1 reference

18 November 2017

0 references

0 references

Antonio C Mattos

4

0 references

Sergio Sosa-Estani

7

object named as

Sergio Sosa-Estani

1 reference

18 November 2017

8

Salim Yusuf

1 reference

18 November 2017

3

Alvaro Avezum

1 reference

18 November 2017

J Antonio Marin-Neto

1

1 reference

18 November 2017

Anis Rassi

2

1 reference

18 November 2017

Anis Rassi

5

1 reference

18 November 2017

Carlos A Morillo

6

1 reference

18 November 2017

BENEFIT Investigators

9

1 reference

18 November 2017

1 July 2009

1 reference

Memórias do Instituto Oswaldo Cruz

18 November 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 November 2017

104 Suppl 1

1 reference

18 November 2017

319-324

1 reference

Functional alterations of the autonomic nervous system in Chagas' heart disease

18 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Chagas disease: what is known and what is needed--a background article

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Problems and perspectives for Chagas disease control: in search of a realistic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

The indeterminate form of human chronic Chagas' disease A clinical epidemiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900042

10.1590/S0074-02762009000900042

21 January 2018

Identifiers

DOI

1 reference

release_fqkujp6c4zb3hhyfhcpqewzvxm

18 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fqkujp6c4zb3hhyfhcpqewzvxm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference